X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2140) 2140
Publication (115) 115
Book Chapter (14) 14
Book / eBook (6) 6
Book Review (6) 6
Dissertation (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1345) 1345
male (1165) 1165
female (962) 962
thromboxane b2 - urine (857) 857
adult (701) 701
animals (661) 661
middle aged (573) 573
thromboxane b2 - analogs & derivatives (479) 479
thromboxane (458) 458
rats (426) 426
prostacyclin (368) 368
6-ketoprostaglandin f1 alpha - urine (361) 361
index medicus (335) 335
aged (323) 323
aspirin (283) 283
thromboxane b2 - blood (251) 251
peripheral vascular disease (210) 210
prostaglandins (204) 204
platelet aggregation - drug effects (199) 199
pharmacology & pharmacy (193) 193
aspirin - pharmacology (192) 192
thromboxane-a synthase - antagonists & inhibitors (170) 170
hematology (167) 167
6-ketoprostaglandin f1 alpha - analogs & derivatives (160) 160
blood platelets - drug effects (158) 158
thromboxane a2 - biosynthesis (153) 153
blood pressure - drug effects (152) 152
kidney - drug effects (152) 152
prostaglandins - urine (147) 147
kidney - metabolism (137) 137
platelets (136) 136
aspirin - administration & dosage (135) 135
aspirin - therapeutic use (134) 134
biochemistry & molecular biology (132) 132
blood platelets - metabolism (131) 131
cardiac & cardiovascular systems (131) 131
pregnancy (130) 130
adolescent (129) 129
inhibition (128) 128
time factors (127) 127
epoprostenol - biosynthesis (126) 126
metabolites (126) 126
platelet activation (126) 126
endocrinology & metabolism (125) 125
rats, inbred strains (125) 125
oxidative stress (124) 124
radioimmunoassay (123) 123
double-blind method (121) 121
thromboxane a (121) 121
low-dose aspirin (118) 118
biosynthesis (117) 117
thromboxane b2 - metabolism (116) 116
thromboxanes - urine (114) 114
dose-response relationship, drug (113) 113
epoprostenol - urine (113) 113
hypertension (113) 113
urology & nephrology (113) 113
platelet aggregation inhibitors - pharmacology (111) 111
thromboxane a2 - urine (111) 111
thromboxane biosynthesis (110) 110
prostaglandin (109) 109
dinoprostone - urine (106) 106
blood pressure (105) 105
disease (102) 102
prospective studies (98) 98
thromboxane a2 - metabolism (98) 98
reference values (97) 97
urine (97) 97
risk (96) 96
thromboxanes (96) 96
physiological aspects (95) 95
myocardial-infarction (94) 94
inflammation (93) 93
rats, sprague-dawley (93) 93
thromboxanes - biosynthesis (93) 93
cyclooxygenase inhibitors - pharmacology (92) 92
risk factors (91) 91
plasma (90) 90
dinoprost - urine (89) 89
thromboxane b2 - biosynthesis (89) 89
platelet aggregation (88) 88
atherosclerosis (86) 86
biomarkers - urine (86) 86
renin - blood (85) 85
kidney - physiopathology (84) 84
cell biology (83) 83
dinoprost - analogs & derivatives (83) 83
glomerular filtration rate - drug effects (82) 82
creatinine - urine (80) 80
thromboxane a2 (80) 80
indomethacin - pharmacology (79) 79
mice (76) 76
platelet aggregation inhibitors - therapeutic use (76) 76
arachidonic acid (75) 75
drug resistance (75) 75
prostaglandins e - urine (75) 75
expression (74) 74
hypertension - physiopathology (74) 74
kidney (74) 74
physiology (74) 74
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2099) 2099
Japanese (56) 56
Chinese (12) 12
French (8) 8
Russian (6) 6
Italian (5) 5
German (4) 4
Spanish (3) 3
Czech (2) 2
Hungarian (2) 2
Persian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Chemistry and Laboratory Medicine, ISSN 1434-6621, 03/2009, Volume 47, Issue 3, pp. 311 - 320
: The objective of this study was to obtain baseline data on biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in smokers, former smokers... 
evaluation | potential reduced-exposure products | cardiovascular risk | biomarkers | smoking | Potential reduced-exposure products | Biomarkers | Evaluation | Cardiovascular risk | Smoking | C-REACTIVE PROTEIN | METABOLITES | OXIDATIVE DNA-DAMAGE | THROMBOXANE A2 | URINARY-EXCRETION | MASS-SPECTROMETRY | WOMEN | CIGARETTE-SMOKING | POLYMORPHISMS | 8-HYDROXYDEOXYGUANOSINE | MEDICAL LABORATORY TECHNOLOGY | Nitrosamines - urine | Deoxyguanosine - blood | Dinoprost - blood | Biomarkers - urine | Immunoglobulin G - blood | Humans | Middle Aged | Male | Cholesterol, LDL - urine | Thymidine - urine | Thymidine - blood | Adult | Cholesterol, LDL - blood | Female | Dinoprost - analogs & derivatives | Deoxyguanosine - analogs & derivatives | Nitrosamines - blood | Immunoglobulin G - urine | Reproducibility of Results | Cross-Sectional Studies | Deoxyguanosine - urine | Dinoprost - urine | Smoking - blood | Smoke - adverse effects | Biomarkers - blood | Thromboxane B2 - analogs & derivatives | Pyridines - blood | Thymidine - analogs & derivatives | Thromboxane B2 - urine | Aged | Smoking - urine | Thromboxane B2 - blood | Pyridines - urine | Nicotine - urine | Smoking Cessation | Urine | Smokers | Analysis | Ex-smokers | Nonsmokers | Research | Cardiovascular diseases | Health aspects | Risk factors | Genetic polymorphisms | Index Medicus
Journal Article
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, ISSN 1618-2642, 02/2015, Volume 407, Issue 6, pp. 1625 - 1639
Journal Article
Food Chemistry, ISSN 0308-8146, 04/2015, Volume 173, pp. 1187 - 1194
Journal Article
American Journal of Veterinary Research, ISSN 0002-9645, 12/2016, Volume 77, Issue 12, pp. 1340 - 1345
Journal Article
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, ISSN 0731-7085, 09/2016, Volume 129, pp. 148 - 154
The balance between vascular prostacyclin (PGI(2)) generated mainly via cyclooxygenase-2 (COX-2) and its physiological antagonist platelet-derived thromboxane... 
UHPLC/MS/MS method | CHEMISTRY, ANALYTICAL | THROMBOXANE | Eicosanoids | Thromboxane A | PHARMACOLOGY & PHARMACY | Prostacyclin | NO-deficient mice
Journal Article
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 09/2016, Volume 129, pp. 148 - 154
Journal Article
Circulation, ISSN 0009-7322, 10/2008, Volume 118, Issue 17, pp. 1705 - 1712
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 09/2006, Volume 80, Issue 3, pp. 264 - 274
Background and Objective We performed a placebo‐controlled, randomized study to address whether celecoxib or ibuprofen undermines the functional range of... 
LOW-DOSE ASPIRIN | MYOCARDIAL-INFARCTION | COX-2 | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACETYLATION | CYCLOOXYGENASE INHIBITION | PLATELET | RISK | PHARMACOLOGY & PHARMACY | THROMBOXANE BIOSYNTHESIS | NAPROXEN | Ibuprofen - therapeutic use | Pyrazoles - therapeutic use | Humans | Middle Aged | Male | Osteoarthritis - drug therapy | Aspirin - administration & dosage | Sulfonamides - urine | Platelet Aggregation Inhibitors - urine | Platelet Aggregation Inhibitors - administration & dosage | Female | Aspirin - therapeutic use | Platelet Aggregation - drug effects | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Double-Blind Method | Drug Administration Schedule | Platelet Function Tests - methods | Myocardial Ischemia - blood | Ibuprofen - administration & dosage | Osteoarthritis - blood | Treatment Outcome | Celecoxib | Myocardial Ischemia - drug therapy | Thromboxane B2 - analogs & derivatives | Adenosine Diphosphate - pharmacology | Pyrazoles - administration & dosage | Pyrazoles - urine | Sulfonamides - therapeutic use | Thromboxane B2 - urine | Arachidonic Acid - pharmacology | Ibuprofen - urine | Aspirin - urine | Aged | Thromboxane B2 - blood | Sulfonamides - administration & dosage | Medical colleges | Care and treatment | Cardiac patients | Myocardial ischemia | Angiogenesis inhibitors | Nonsteroidal anti-inflammatory drugs | Osteoarthritis
Journal Article
Journal Article
Drug Testing and Analysis, ISSN 1942-7603, 06/2019, Volume 11, Issue 6, pp. 792 - 803
Phenylbutazone (PBZ) is a potent mon‐steroidal anti‐inflammatory drug used commonly in performance horses. The objectives of the current study were to describe... 
horse | pharmacokinetics | eicosanoids | phenylbutazone | inflammation | CHEMISTRY, ANALYTICAL | BIOCHEMICAL RESEARCH METHODS | PHARMACODYNAMICS | OXYPHENBUTAZONE | INHIBITION | PLASMA | THROMBOXANE | PASTE | DRUGS | PHARMACOLOGY & PHARMACY | ABSORPTION | Phenylbutazone | Mass spectrometry | Inflammation
Journal Article
Journal Article
Journal Article